SURMOUNT-1 investigated tirzepatide in adults without diabetes
The advantage of compounded tirzepatide is accessibility across all 50 states without insurance requirementsquality and stability remain consistent
If you are a patient at Primary Care Center of Clear Lake and have reached a weight loss plateau while using Wegovy (semaglutide), you may be wondering if switching to Zepbound (tirzepatide) could help you continue your progress
Other side effects shared in these reviews include heart palpitations, sweating, nausea, shortness of breath, and fatigue
At the same time, compelling cardiovascular outcomes data will be equally critical for commercial success to demonstrate value to health systems: Novos SELECT trial read out in 2023, demonstrating the impact of Wegovy-induced weight loss was a statistically significant 20% reduction in a composite endpoint consisting of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke in 17,604 overweight or obese patients with prior cardiovascular disease